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Objectives: To identify reasons for delay before carotid endarterec-
tomy (CEA) in a reconﬁgured “fast-track” system where patients were
admitted from the TIA (transient ischaemic attack) Clinic for urgent
CEA.
Methods: Prospective audit in 89 recently symptomatic patients.
Results: Ten patients (11%) suffered recurrent symptoms between
admission and surgery. Two strokes were sufﬁciently severe that CEA was
cancelled. The median delay from index symptom to CEA was 8 days.
74/87 (85%) underwent CEA <14 days from the index symptom; 39/87
(45%) within 7 days. Forty-ﬁve (51%) were ready for CEA <24 hours of
admission; 74 (83%) <72 hours. The most common reasons for delay to
CEA were logistical, especially a failure to plan for access to weekend oper-
ating. Two-thirds of the Tuesday/Friday theatre lists that were reserved for
urgent CEAs were actually used for CEA; 27 (33%) were not used for CEA
but were utilized for another vascular procedure, and ﬁve (4%) were
cancelled the day before and went unused.
Conclusions: The vast majority of patients (85%) underwent CEA
<14 days from the index symptom, but 11% still suffered recurrent symp-
toms prior to surgery. Transferring patients directly from the TIA Clinic
reduced overall delays, but Vascular Units adopting such an approach
might then be vulnerable to criticisms regarding prolonged lengths of
pre-operative in-patient stay while patients were worked up for theatre.
Protected theatre lists both optimized (and delayed) access to CEA, but
the most important cause of delay was that we had not planned for
weekend operating using specialist anaesthetic and theatre staff.
The Beneﬁts of EVAR Planning Using a 3D Workstation
Sobocinski J., Chenorhokian H., Maurel B., Midulla M., Hertault A.,
Le Roux M., Azzaoui R., Haulon S. Eur J Vasc Endovasc Surg 2013;
46:418-23.
Objectives: To evaluate the inﬂuence of planning endovascular aneu-
rysm repair (EVAR) with a three-dimensional (3D) workstation on early
and midterm outcomes.
Methods: All patients undergoing infrarenal EVAR performed
between 2006 and 2009 at our institution were included in the current
study. Prior to 2008 (group 1), endograft sizing was performed by interro-
gation of computed tomography angiography axial images. After 2008
(group 2), endograft sizing was routinely performed using a 3D workstation
(Aquarius, Terarecon), allowing for multiplanar reconstruction and center-
line analysis. Pre-, peri-, postoperative, and follow-up data were prospec-
tively entered in an electronic database. All postoperative complications
and subsequent secondary interventions depicted during the 2-year period
following EVAR were compared. Secondary intervention and mortality rates
were deﬁned at 2 years and compared. Freedom from secondary interven-
tion and overall survival rates were calculated using the Kaplan-Meier
method during follow-up and compared by log-rank test.
Results: A total of 295 patients (149 patients in group 1 and 146
patients in group 2) were included. All patients had completed a minimum
of 2 years of follow-up. During this 2-year period following EVAR, the type
1 endoleak rate was 8.7% in group 1 and 1.4% in group 2 (P = .004) respec-
tively. Secondary intervention rates related to type 1 endoleak was 5.4% in
group 1 and 0 in group 2 (P < .001). No difference was observed regarding
all-cause mortality, aneurysm-related death, and freedom from secondary
intervention rates during follow-up.
Conclusion: The routine use of 3D workstations for EVAR planning
signiﬁcantly reduces the rate of type 1 endoleaks and, therefore, the rate of
related secondary interventions.Occupational Radiation Exposure During Endovascular Aortic
Procedures
Patel A.P., Gallacher D., Dourado R., Lyons O., Smith A., Zayed H.,
Waltham M., Sabharwal T., Bell R., Carrell T., Taylor P., Modarai B. Eur
J Vasc Endovasc Surg 2013;46:424-30.
Objectives: To measure the radiation exposure of the operating team
during endovascular aortic procedures, and to determine factors that predict
high exposures.
Materials and methods: Electronic dosimeters placed over and under
protective lead garments, were used to prospectively record radiation expo-
sure during endovascular aortic repairs performed in a designated interven-
tional radiology suite. Univariate and multivariate linear regression analyses
of predictors of radiation exposure were performed.
Results: A total of 26 infra-renal and 10 thoracic endovascular cases
were studied. Median (IQR) patient age and body mass index were 76.0
(70.0-81.8) years and 26.2 (23.9-28.9) kg/m2 respectively. Over-lead
exposure to the operator was higher for thoracic than for infra-renal proce-
dures (421.0 [233.8-597.8] mSv vs. 52.5 [27.8-179.8] mSv, P = .0003),
reﬂecting a signiﬁcant exposure to unprotected parts of the body. Under-
lead exposures for operator and assistant were 5.5 (2.0-14.2) mSv and 1.0
(0.0-2.3) mSv respectively, which for an average caseload would comply
with total body effective dose limits. Type of case and percentage of digital
subtraction angiography (DSA) time in left anterior oblique angulations
predicted dose to the operator (P < .0001).
Conclusions: Thoracic procedures, DSA runs and obliquity of the C-
arm are strong predictors of radiation exposure during endovascular aortic
repairs. Understanding scatter radiation dynamics and instigating measures
to minimise radiation exposure should be mandatory.
The Morphological Applicability of a Novel Endovascular Aneurysm
Sealing (EVAS) System (Nellix) in Patients with Abdominal Aortic
Aneurysms
Karthikesalingam A., Cobb R.J., Khoury A., Choke E.C., Sayers R.D.,
Holt P.J., Thompson M.M. Eur J Vasc Endovasc Surg 2013;46:440-5.
Objective: Endovascular aneurysm sealing (EVAS) using the Nellix
system is a promising alternative to endovascular repair (EVR) and open
surgery for abdominal aortic aneurysms (AAA). The aim of this study was
to investigate the proportion of patients with AAA who are morphologically
suitable for treatment with Nellix.
Methods: Patients presenting with AAA were investigated at two
regionalised vascular units. Separate cohorts were identiﬁed, who had
undergone infrarenal EVR, open aneurysm repair, fenestrated endovascular
repair (FEVR) or non-operative management. Pre-operative morphology
was quantiﬁed using three-dimensional computed tomography according
to a validated protocol. Each aneurysm was assessed for compliance with
the instructions for use (IFU) of Nellix.
Results: 776 patients were identiﬁed with mean age 75 6 9 years.
730/776 (94.1%) had undergone infrarenal EVR, 6/776 (0.8%) open
repair, 27/776 (3.5%) FEVR and 13/776 (1.7%) had been managed
non-operatively. 544/776 (70.1%) of all AAA were morphologically suit-
able for Nellix. 533/730 (73.0%) of patients who had undergone infrarenal
EVR were compliant with Nellix IFU, compared with 497/730 (68.1%),
379/730 (51.9%) and 214/730 (29.3%) with the IFU for Medtronic
Endurant (P = .04) or Cook Zenith (P < .01) and Gore C3 Excluder
(P < .01) endografts respectively.
Conclusions: Nellix technology appears widely applicable to contem-
porary infrarenal AAA practice, and may provide an option for patients that
are outside current EVR device instructions for use. However, formal
outcomes study is still required, and will ultimately dictate the clinical rele-
vance of this feasibility study. The major limitation to anatomic suitability
for Nellix is currently the maximum patent lumen diameter of large AAA.1143
